Frontlight ResearchEarly access
CompletedNo phase
High-frequency Alternating Current Stimulation for Neurophatic Pain in Spinal Cord Injury
Key facts
- Who runs it
- University of Castilla-La Mancha
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 30 Jan 2026
- Ended
- 7 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active group 40 kHz
- Sham intervention
- Record updated
- 13 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (18)Hide the full registry criteria
Who can take part
- People with spinal cord injuries of any aetiology affecting the D1 spinal cord level or lower (paraplegia)
- With injury grade A, B, C, or D according to the ASIA (American Spinal Injury Association) Impairment Scale (AIS)
- Time since spinal cord injury ≥ 3 months
- A score of ≥ 4 points on the Dolour Neuropathique 4 (DN4) scale
- Neuropathic pain at the level of the injury (within the dermatome at that level and up to three dermatomes below) and/or below the level of the injury (more than three dermatomes below)
- Duration of pain ≥ 1 month
- Average pain perception score ≥ 30 mm on the visual analogue scale (VAS) in the week prior to eligibility, with a daily record of 5 days (Monday to Friday) in the morning
- Be able to understand instructions and assessment tools
- Agree to participate in the study and sign the informed consent form
Who cannot take part
- Brain injuries or other central nervous system injuries concomitant with spinal cord injury
- A value of 100 mm in any of the daily records collected in the week prior to eligibility
- Changes in medication prescribed for the treatment of pain and spasticity during the study
- Having any contraindications for the application of transcutaneous electrical stimulation: cardiac pacemaker or any other implanted electrical device, epilepsy, pregnancy, active malignant tumours in the area of application of the stimulation, and wounds or skin damage in the area of stimulation
- History of psychiatric illness
- Cauda equina injuries
- Major depression
- Spinal cord injury caused by autolysis
- Acute nociceptive pain in any area of the body during the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To investigate the safety and effectiveness of transcutaneous electrical stimulation with 40 kHz alternating currents combined with standard treatment compared to placebo electrical stimulation plus standard treatment for neuropathic pain in people with spinal cord injury.
The 2 groups in the trial
- Experimental: 40 kHzTreatment being tested
Alternating current stimulation with a 40kHz frequency with a transcutaneous approach, 20 minutes for each intervention.
Treatment: Active group 40 kHz
- Sham stimulationSham treatment, for comparison
Sham stimulation via transcutaneous approach will be delivered only for the first 30 seconds, following the same procedures as the 40kHz group.
Treatment: Sham intervention
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effectiveness and Safety of Transcutaneous Electrical Stimulation With 40 kHz Alternating Currents in People With Spinal Cord Injury and Neuropathic Pain. A Randomised, Double-blind, Parallel Pilot Study With Placebo Control
- Record updated
- 13 April 2026